Xiaohong Xu
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 9
- Cancer, Hypoxia, and Metabolism 6
- Molecular Biology top 5%
- RNA Research and Splicing 8
- RNA modifications and cancer 7
- Mitochondrial Function and Pathology 6
- Pluripotent Stem Cells Research 6
- Genomics, phytochemicals, and oxidative stress 5
- Aging top 10%
-
- Genetic Neurodegenerative Diseases 8
- Oncology top 10%
- Co-authors
- Mahmoud A. PouladiZhong ZhongAndrew J. McMichaelGregory D. PlowmanMichael KalosJason R. ManroYanxia LiKarim A. Benhadji
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiaohong Xu
95 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 369
- Molecular Biology 1.3k
- Aging 28
- Cellular and Molecular Neuroscience 283
- Oncology 357
Countries citing papers authored by Xiaohong Xu
This map shows the geographic impact of Xiaohong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Xu more than expected).
Fields of papers citing papers by Xiaohong Xu
This network shows the impact of papers produced by Xiaohong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Xu. The network helps show where Xiaohong Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaohong Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 15 | |
| 9 | 2023 | 2 | |
| 10 | 2021 | 13 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 10 | |
| 13 | 2020 | 18 | |
| 14 | 2017 | 140 | |
| 15 | 2017 | 1 | |
| 16 | Outcome prediction values of soluble human epidermal growth factor receptor-2 extracellular domain in metastatic breast cancer. | 2014 | 6 |
| 17 | To Observe the Effect of Oxiracetam Combined Acetylglutamide on Sequelae of Cerebral Infarction | 2013 | 1 |
| 18 | 2012 | 92 | |
| 19 | Advances in study on iridoids in plants of Swertia L. and their pharmacological activity | 2008 | 7 |
| 20 | The progress of biological research of medicinal fungus Shiraia bambusicola | 2006 | 7 |
About Xiaohong Xu
Xiaohong Xu is a scholar working on Cancer Research, Molecular Biology and Developmental Neuroscience, having authored 101 papers that have together received 2.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Genetic Neurodegenerative Diseases (8 papers), RNA Research and Splicing (8 papers), RNA modifications and cancer (7 papers), Mitochondrial Function and Pathology (6 papers), Pluripotent Stem Cells Research (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Genomics, phytochemicals, and oxidative stress (5 papers). The work is most often cited by research in Cancer Research (369 citations), Molecular Biology (1.3k citations) and Aging (28 citations). Xiaohong Xu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Mahmoud A. Pouladi, Zhong Zhong, Andrew J. McMichael, Gregory D. Plowman, Michael Kalos, Jason R. Manro, Yanxia Li, Karim A. Benhadji, Rikke Holmgaard and Ivan Inigo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.